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ABSTRACT
Background. Extraintestinal pathogenic Escherichia coli (ExPEC) is an important
bacterium and responsible for many bloodstream infections, including urinary tract
infections and even fatal bacteremia. The aim of this research was to investigate whether
ExPEC strains isolated from Turkish blood cultures have a relationship between 16S
rRNA based phylogenetic clusters and antibiotic resistance profiles, virulence factors
or clonal lineages.
Methods. Phenotypically identified ExPEC blood culture isolates (n = 104) were
included in this study. The 16S rRNA partial sequence analysis was performed for
genotypic identification of ExPEC isolates. Antibiotic susceptibility and Extended-
Spectrum β-Lactamase testing of isolates were performed. Phylogenetic classification
(A, B1, B2 and D), Multi Locus Sequence Typing analysis and virulence-associated
genes were investigated.
Results. Based on 16S rRNA partial sequence analysis, 97 out of 104 (93.26%)
ExPEC isolates were confirmed as E. coli. Ampicillin (74.22%) and cefuroxime axetil
(65.97%) resistances had the highest frequencies among the ExPEC isolates. In terms of
phylogenetic classification of ExPEC, D (38.14%, 37/97) was the most prevalent group
after A (29.89%, 29/97), B2 (20.61%, 20/97), and B1 (11.34%, 11/97). The sequence
types of the 20 ExPEC isolates belonging to the B2 phylogenetic group were analyzed by
Multi Locus Sequence Typing. Ten isolates out of 20 (50.0%) were identified as ST131.
The other STs were ST95 (n= 1), ST14 (n= 1), ST10 (n= 1), ST69 (n= 1), ST1722
(n= 2), ST141 (n= 1), ST88 (n= 1), ST80 (n= 1), and ST998 (n= 1). Of the ST131
strains, six (60%, 6/10) represented serogroupO25. Themost common virulence factor
genes were serum resistance factor gene, traT (55.7%) aerobactin siderophore receptor
and yersiniabactin encoding genes iutA (45.3%) and fyuA (50.5%), respectively. In
addition, PAI (41.2%), iroN (23.7%), hlyA (15.4%), kpsII (13.4%), ompT (13.4%),
papG (12.4%), iss (9.3%), cnf1 (7.2%), ibeA (2.06%), and sfaS (2.06%) genes were
present in the ExPEC isolates.
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Conclusion. The 16S rRNA-based phylogenetic relationship tree analysis showed that a
large cluster was present among 97 ExPEC isolates along with related reference strains.
There were 21 main clusters with 32 closely related subclusters. Based on our findings,
different clonal lineages of ExPEC can display different antibiotic susceptibilities and
virulence properties. We also concluded that virulence factors were not distributed
depending on phylogenetic groups (A, B1, B2, and D). The ExPEC isolates belonging
to the same phylogenetic group and sequence type could display different resistance
and virulence characteristics.
Subjects Microbiology, Epidemiology, Infectious Diseases, Public Health
Keywords Escherichia coli, 16S rRNA, antibiotic resistance, MLST, Virulence, ST131
INTRODUCTION
Escherichia coli (E. coli) is one of the most thoroughly studied bacterium of the human
intestinal system (Koga et al., 2014). Despite the occurrence of commensal strains in the
intestinal microbiota, E. coli can cause to various infections not only in the intestinal system
but also in the bloodstream. E. coli that can cause infections outside the intestinal system are
designated as extra intestinal pathogenic E. coli (ExPEC) (Ananias & Yano, 2008; Fratamico
et al., 2016). ExPEC can initiate systemic infections by causing sepsis or bacteremia that
may disseminate bacteria to tissues and organs including the urinary tract, central nervous
system, and deep surgical wound areas (Chouikha et al., 2006; Lloyd et al., 2009).
ExPEC has been divided into four groups (A, B1, B2, and D) according to the
phylogenetic classification. Pathogenic groups of ExPEC strains generally belong to
groups B2 and D. However, commensal strains that survive in the intestinal system,
i.e., non-pathogenic strains, are generally included in groups A or B1 (Clermont, Bonacorsi
& Bingen, 2000). In addition to the phylogenetic grouping, Multi-Locus Sequence Typing
(MLST) of ExPEC is a typing method used to identify clinically significant ExPEC ST
lineages where strains fall into certain STs and/or ST complexes.
Pathogenic groups of ExPEC in relation to ST lineages are common worldwide. The
most prevalent lineages of ExPEC are ST131/B2, ST127/B2, ST95/B2, ST73/B2, and ST69/D
in the UK (Ciesielczuk et al., 2016). The most widespread lineages of ExPEC were ST95
followed by ST131 in the United States (Stephens et al., 2017). The B2/ST131 lineage is
the most common in Italy (Cerquetti et al., 2010). Of the clonal groups of ST131, the
percentage of Extended Spectrum β-lactamase (ESBL) producing ExPEC was 45.8% in
Germany and 41% in southern of Europe and 39.9% in Turkey (Aktaş et al., 2017; Arvand,
Moser & Pfeifer, 2013; Pomba et al., 2014).
ExPEC are generally encountered as urinary pathogens (Dale & Woodford, 2015).
Accordingly, urinary tract-associated E. coli remain a health problem in Turkey (Koksal et
al., 2017). Moreover, the prevalence of E. coli originating from urinary tract systems is over
50% in Turkey (Yilmaz et al., 2016a; Yilmaz et al., 2016b). Nevertheless, E. coli strains have
been isolated from blood associated with bacteraemia in Turkey (Kaya et al., 2013).
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A notable increase in antibiotic resistance generates difficulties in the treatment of
extra intestinal infections caused by ExPEC (Cerquetti et al., 2010;Matsumura et al., 2017).
ExPEC generally exhibits resistance to cephalosporins, fluoroquinolones, beta-lactams,
and sulphonamides (Blanco et al., 2011; Feglo et al., 2013). In particular, CTX-M type ESBL
producing ExPEC is significant in terms of public health. The ST131 lineages belong to the
B2 group and are the most prevalent among ExPEC. Thus, ExPEC in the B2 phylogenetic
group and ST131 lineages produce CTX-M type β-lactamase as well as fluoroquinolones
resistant (Arvand, Moser & Pfeifer, 2013). Moreover, the H30 sub-lineage of ST131 has
also emerged worldwide. The H30 sub-lineage of ST131 produces VIM-1 and KPC-3
carbapenemases in Italy (Accogli et al., 2014). Similarly, a high percentage of CTX-M type
β-lactamase producing E. coli has been reported from Turkey (Aktaş et al., 2017).
ExPEC has a broad range of virulence factors (VFs), and they include genetically
diverse strains. The VFs are encoded by chromosomal genes, and they are often located
in pathogenicity islands (PAIs) or plasmids (Dale & Woodford, 2015). VFs are attributed
to various bloodstream infections including urinary tract infection and septicaemia. The
ExPEC is the main reason for infections out of the intestinal system. Thus, virulence
factors generally comprise an iron acquisition system, surface structures, toxins and outer
membrane proteins e.g., haemolysin, cytotoxic necrotizing factor, yersiniabactin, fimbriae,
serum survival, and capsule synthesis (Koga et al., 2014; Subashchandrabose & Mobley,
2015).
Some ExPEC phylogenetic groups are responsible for various extraintestinal infections,
and many ExPEC lineages are resistant to many antibiotics. The ExPECs studied here
were isolated from blood samples in Turkish Hospital and had relationships among clonal
lineages, antibiotic resistance, and virulence factors. Therefore, the aim of this study was to
investigate phylogenetic relationship between virulence, clonal properties, and antibiotic
resistance profiles among ExPEC isolates originated from Izmir Province in Turkey.
METHODS
Bacterial isolates
Presumed ExPEC isolates (n= 104) isolated from blood cultures were obtained from
the bacterial culture collection of Ege University-Department of Medical Microbiology
Laboratory. Ege University Hospital is a 1900–2000 bed capacity hospital. The clinical
information on the ExPEC isolates is shown in Fig. 1. All isolates were identified by
MALDI-TOF Mass Spectrometry (BioMérieux, Craponne, France). The isolates were
stored in Luria Bertani Broth (LB) with 50% glycerol at −80 ◦C until further analysis.
Colonies with a metallic green sheen were selected after culturing the strains on Eosin
Methylene Blue Agar (EMB) plates (Merck, Kenilworth, NJ, USA). The control strains,
E. coli CFTO73 and E. coli O25b:H4 (JJ1886), were kindly provided by Prof. James R.
Johnson (University of Minnesota, VA Medical Centre, USA). Escherichia coli O25:H4
(DSM 22664 strain) was purchased from German Collection of Microorganisms and
Cell Cultures. The quality control strain E. coli ATCC 25922 was obtained from Ege
University-Department of Medical Microbiology.
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Figure 1 Distribution of hospital departments among ExPEC isolates. The number of departments




Antibiotic susceptibility and ESBL testing of the isolates was performed by an
automated method (VITEK R©2 BioMérieux). Susceptibility to 13 antibiotics including
ampicillin, amoxicillin plus clavulanic acid, cefuroxime axetil, ceftriaxone, trimethoprim-
sulfamethoxazole, cefepime, gentamicin, piperacillin/tazobactam, ciprofloxacin, amikacin,
ertapenem, ceftazidime, and cefuroxime was tested using the Gram Negative Susceptibility
card (AST-N325). Antibiotics for each isolate may vary because antibiotic susceptibility
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testing was applied to all ExPEC isolates within routine diagnosis. The McFarland standard
was 0.5 (1.5 × 108 cfu/ml). VITEK 2 cards were inoculated with E. coli bacterium via
an integrated apparatus. The test tube with the bacterial suspension was placed into the
cassette. Next, the AST card was inserted into the part of slot while inserting the transfer
tube into the corresponding suspension tube. The prepared cassettes were transported
into the chamber and incubated online at 35.5+1.0 ◦C. Escherichia coli ATCC 25922 was
used as a control strain. Interpretation of the antibiotic susceptibility testing results was
performed using the guidelines from the Clinical & Laboratory Standards Institute (CLSI,
2013). The susceptibility results were obtained and reported as resistant (R), sensitive
(S) and intermediate resistant (I). The MIC breakpoint (µg/ml) of each antibiotic was
as follow: ampicillin (R8,I:- S ≤ 8), amoxicillin plus clavulanic acid (R ≥ 8, I = 16 S
≤ 8), cefuroxime axetil (R ≥ 8, I = 16 S ≤ 8), ceftriaxone (R > 4, I = 2 and S ≤ 1),
trimethoprim-sulfamethoxazole (R ≥4/76, I:- and S ≤2/38), cefepime (R ≥ 32, I = 16 and
S≤ 8), gentamicin (R≥ 16, I = 8 and S≤ 4), piperacillin/tazobactam (R≥ 128, I = 32–64
and S ≤ 16), ciprofloxacin (R ≥ 4, I = 2 and S ≤ 1), amikacin (R ≥ 64, I = 32 and S ≤
16), ertapenem (R ≥ 2, I = 1 and S ≤ 0.5), ceftazidime (R ≥ 16, I = 8 and S ≤ 4) and
cefuroxime (R ≥ 32, I = 16, S ≤ 8).
Genomic DNA Isolation
Isolation of the bacterial genomic DNA was performed using either the Wizard R©Genomic
DNA Purification Kit (Promega, Madison, WI, USA) or the JetFlex Genomic DNA
Purification Kit (Thermo Fisher Scientific, Waltham, MA, USA). Plasmid DNA isolation
was performed with a Pure Yield Plasmid MiniPrep System kit (Promega). Isolated DNA
samples were stored at −20 ◦C for further analysis.
16S rRNA PCR
The 16S rRNA PCR analysis was modified from Frank et al. (2008). The 1,465 bp fragment
of the 16S rRNA gene was amplified in a 50 µl reaction volume containing 1× PCR buffer
(Thermo Fisher Scientific), 0.2 mM of each dNTP, 2 mM MgCl2, and 0.5 µM of each
primer (16S rRNA universal primers: 27F and 1492R) (Table 1). The reaction conditions
were of 2 min at 95 ◦C initial denaturation, 25 cycles of 1 min at 95 ◦C, 1 min at annealing
temperature (55 ◦C), and 2 min at 72 ◦C followed by 10 min at 72 ◦C final extension.
The PCR amplicons were analysed in agarose gel electrophoresis and visualized using the
WiseDoc Gel Doc System WiseUV Transilluminator.
DNA sequence analysis
The resulting partial 16S rRNA gene PCR products were purified by BMLabosis (Ankara,
Turkey) using the ExoSap-IT (Affymetrix) kit. The purified samples were sent to Macrogen
(Amesterdam, The Netherlands) where the fragments were unidirectionally sequenced
using the ABI 3730XL automated sequencer (Applied Biosystems, Foster City, CA,
USA), and the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems).
The resulting sequence reads were aligned and trimmed using the SILVA (Quast et al.,
2013) and DNA Baser Assembler Software programs, respectively. Before phylogenetic
analysis, all ambiguously aligned regions and gaps were removed with trimAL (v1.4) using
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Table 1 Primers used in this study.
Gene Sequence (5′ → 3′) Size (bp) Description Reference
chuA GAC GAA CCA ACG GTC AGG AT 279 Hemetransport in Enterohemor-
rhagic O157:H7 E.coli
Clermont, Bonacorsi & Bingen (2000)
TGC CGC CAG TAC CAA AGA CA
yjaA TGA AGT GTC AGG AGA CGC TG 211 Protein of function unknown Clermont, Bonacorsi & Bingen (2000)
ATG GAG AAT GCG TTC CTC AAC
TSPE4.C2 GAG TAA TGT CGG GGC ATT CA 152 Putative DNA fragment
(TSPE4.C2) in E. coli
Clermont, Bonacorsi & Bingen (2000)
CGC GCC AAC AAA GTA TTA CG
hlyA AAC AAG GAT AAG CAC TGT TCT
GGC
1,777 Hemolysin Koga et al. (2014)
ACC ATA TAA GCG GTC ATT CCC
GTC
cnf1 AAGATGGAG TTT CCT ATGCAGGAG 498 Cytotoxic necrotizing factor 1 Johnson & Stell (2000)
CAT TCA GAG TCC TGC CCT CAT
TAT T
iutA GGC TGG ACA TCA TGG GAA CTG G 302 Aerobactin siderophore receptor Koga et al. (2014)
CGT CGG GAA CGG GTA GAA TCG
fyuA TGA TTA ACC CCG CGA CGG AA 880 Yersiniabactin Johnson & Stell (2000)
CGC AGT AGG CAC GAT CTT GTA
iroN AAT CCG GCA AAG AGA CGA ACC
GCC T
553 Salmochelin siderophore receptor Koga et al. (2014)
GTT CGG GCA ACC CCT GCT TTG
ACT TT
papG CTG TAA TTA CGG AAG TGA TTT
CTG
1,070 P fimbriae Johnson & Stell (2000)
ACT ATC CGG CTC CGG ATA AAC
CAT
sfaS GTG GAT ACG ACG ATT ACT GTG 240 Sfa fimbriae Johnson & Stell (2000)
CCG CCA GCA TTC CCT GTA TTC
iss CAG CAA CCC GAA CCA CTT GAT G 323 Episomal increased serum survival Johnson et al. (2008)
AGC ATT GCC AGA GCG GCA GAA
traT GGT GTG GTG CGA TGA GCA CAG 290 Serum resistance Johnson & Stell (2000)
CAC GGT TCA GCC ATC CCT GAG
ibeA AGG CAG GTG TGC GCC GCG TAC 170 Invasion of brain endothelium Johnson & Stell (2000)
TGG TGC TCC GGC AAA CCA TGC
kpsMT II GCGCAT TTGCTGATA CTGTTG 272 Capsule synthesis K1 e K5 Johnson & Stell (2000)
CAT CCA GAC GAT AAG CAT GAG
CA
ompT TCA TCC CGG AAG CCT CCC TCA
CTA CTA T
496 Episomal outer membrane protease Koga et al. (2014)
TAG CGT TTG CTG CAC TGG CTT
CTG ATA C
rfb TACCGACGACGCCGATCTG 300 O-typing O25b serotype Clermont et al. (2008)
TGCTATTCATTATGCGCAGC
(continued on next page)
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Table 1 (continued)
Gene Sequence (5′ → 3′) Size (bp) Description Reference
PAI GGACATCCTGTTACAGCGCGCA 930 pathogenicity-associated island
(PAI) marker
Johnson & Stell (2000)
TCGCCACCAATCACAGCCGAAC
adk ATTCTGCTTGGCGCTCCGGG 583 adenylate kinase Maluta et al. (2014),Wirth et al. (2006)
CCGTCAACTTTCGCGTATTT
fumC TCACAGGTCGCCAGCGCTTC 806 fumarate hydratase Maluta et al. (2014),Wirth et al. (2006)
GTACGCAGCGAAAAAGATTC










932 malate dehydrogenase Maluta et al. (2014),Wirth et al. (2006)
TTAACGAACTCCTGCCCCAGAGCG
ATATCTTTCTT
purA CGCGCTGATGAAAGAGATGA 816 adenylosuccinate dehydrogenase Maluta et al. (2014),Wirth et al. (2006)
CATACGGTAAGCCACGCAGA
recA CGCATTCGCTTTACCCTGACC 780 ATP/GTP binding motif Maluta et al. (2014),Wirth et al. (2006)
AGCGTGAAGGTAAAACCTGTG
16S rRNA AGAGTTTGATCCTGGCTCAG 1,465 16S rRNA, partial gene Suardana (2014)
GGTTACCTTGTTACGACTT
a heuristic best automated parameter ‘‘-automated1’’ and manually assessed (Capella-
Gutierrez, Silla-Martinez & Gabaldon, 2009). The lengths of the good quality sequences
ranged between 901 and 1,261 bp.
Phylogenetic classification based on 16S rRNA sequences
Nucleotide BLAST analysis was performed followed by TrimAI analysis. All 16S rRNA
gene sequences were deposited in the NCBI GenBank database (Dataset S1). To ensure
a reliable identification, the sequence similarities were analysed using the web-based
SINA alignment service with the following criteria: reject sequences below 90% identity
to consensus E. coli sequence and sequences with <700 nt in length (Pruesse, Peplies &
Glockner, 2012). The multiple sequence alignment of 16S rRNA partial sequences was
performed via the MUSCLE (Edgar, 2004). Clustering method was Neighbor Joining
implemented in MEGA 7.0. (Kumar, Stecher & Tamura, 2016). The phylogenetic tree was
inferred by using Maximum Likelihood method based on the Hasegawa–Kishino–Yano
model (Felsenstein, 1985). The bootstrap consensus tree was constructed from 1,000
replicates. The visualization and sub-tree analysis of ExPEC isolates were implemented in
MEGA 7.0 (Kumar, Stecher & Tamura, 2016). Bootstrap cut-off value (≥75%) are given
for each node. To compare the phylogenetic relationship of E. coli isolates with pathogenic
and non-pathogenic ExPEC strains, The sub-tree analysis was involved 111 nucleotide
sequences (ExPEC isolates (n= 97) and related reference ExPEC strains (n= 14)). The
description and accession numbers of reference strains are shown in Table 2.
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Table 2 Extra intestinal pathogenic Escherichia coli (ExPEC) reference strains.
ID_NCBI Strain Description Reference
Escherichia coli AP009378 SE15 Escherichia coli strain SE11 (O152:H28) isolated from feces of a
healthy adult and classified into E. coli phylogenetic group B1
Toh et al. (2010)
Escherichia coliHG941718 EC958 Escherichia coli ST131 Urinary tract infection Forde et al. (2014)
Escherichia coli CP006784 JJ1886 Highly Virulent CTX-M-15-Producing H30-Rx Subclone of
Escherichia coli ST131
Andersen et al. (2013)
Escherichia coli CP002797 NA114 Multidrug-Resistant Uropathogenic Escherichia coli Strain Avasthi et al. (2011)
Escherichia coli AE014075 CFT073 Uropathogenic Escherichia coli strain Welch et al. (2002)
Escherichia coli CU928162 ED1a Commensal strain-isolated in the 2000s from the faeces of a healthy
man in France
Touchon et al. (2009)
Escherichia coli CP000243 UTI89 UTI89 is a uropathogenic Escherichia coli (UPEC) belonging to phy-
logroup B2
Chen et al. (2006)
Escherichia coli CP000468 APECO1 Avian pathogenic Escherichia coli strain isolated from chickens and
turkeys clinically diagnosed with colibacillosis
Johnson et al. (2007)
Escherichia coli CU928161 S88 Isolated in 1999 from the cerebro-spinal fluid of a new born with
late-onset neonatal meningitis in France
Touchon et al. (2009)
Escherichia coli CU928163.2 UMN026 Extraintestinal pathogenic Escherichia coli strain (ExPEC) isolated
from an acute cystitis patient in the USA in 1999
Touchon et al. (2009)
Escherichia coli AP009240 SE11 A commensal bacterium was isolated from the feces of a healthy hu-
man adult. It belongs to the E.coli phylogenetic group B1
Oshima et al. (2008)
Escherichia coli CU928160 IAI1 Isolated from the faeces at 1980s in France Touchon et al. (2009)
Escherichia coli CP000948 DH10B Strain DH10B is a derivative of the already sequenced K12 Durfee et al. (2008)
Escherichia coli U00096 K-12 (MG1655) Escherichia coli strain K-12 was obtained from a stool sample of a
diphtheria patient
Bachmann (1996);
Blattner et al. (1997)
O25b typing
ExPEC isolates belonging to the Group B2 were evaluated for ST131 situation by O25b
rfb detection (Clermont et al., 2009; Johnson et al., 2014). The allele-specific PCR, using the
O25b type primers (Table 1) and the annealing temperature of 60 ◦C producing a PCR
product of 300 bp was performed as described elsewhere (Clermont et al., 2008).
Determination of the ExPEC phylogenetic groups
Phylogenetic classification of the ExPEC strains into the A, B1, B2 and D groups used
triplex PCR, based on amplification of chuA (a gene required for heme transport in
enterohemorrhagic O157:H7 E. coli), yjaA (a gene detected from complete genome
sequence of E. coli K-12 the function of which is unknown), and the DNA fragment
TSPE4.C2 (from subtractive library of E. coli). The PCR used carried out in 50 µl final
volume containing 1.25U DyNAzymeTM II DNA Polymerase (Thermo Fisher Scientific,
Waltham, MA, USA) in 1× PCR buffer, 0.2 µM of each dNTP, 2 mM MgCl2, and 1 µM
of each primer (Table 1). The PCR program included denaturation at 95 ◦C for 4 min,
followed by 30 cycles of 95 ◦C for 5 s and 55 ◦C for 10 s, with a final extension step at
72 ◦C for 5 min (Clermont, Bonacorsi & Bingen, 2000). During the determination of the
phylogenetic classification of the ExPEC isolates, the chuA gene encoding heme transport
in enterohemorragic O157:H7 was the first evaluation step for the assigning the B2 or D
group.
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Virulence factors
A total of 13 virulence factors (VFs) encoded by chromosome or plasmid ,were investigated.
The genes included the PAI marker, the adhesin genes (papG, papC, sfaS), the toxin genes
(hlyA, cnf1), the capsule synthesis gene (kpsII), the siderophore genes (fyuA, iroN, iutA), the
serum resistance genes (iss and traT ), the brain microvascular endothelium invasion gene
(ibeA), and the outer membrane protein gene (ompT ) (Table 1). The VF gene detection
was performed in the triplex, duplex, and/or standard PCR analysis (Triplex PCR: 1.set:
cnf1, papG and sfaS, 2.set: fyuA, iutA and IroN. Duplex PCR: 1. Set: hlyA and kpsII, 2. Set:
iss and traT, 3. Set: PAI and ibeA. Standard PCR: ompT ). PCR conditions were performed
as follows: 1.25U DyNAzymeTMII DNA Polymerase (Thermo Fisher Scientific) in 1x PCR
buffer (Thermo Fisher Scientific), 0.2mM of each dNTP, 2 mM MgCl2, and 1 µM of each
primer (Table 1). The PCR program consisted of a 5 min initial denaturation at 95 ◦C,
followed by 30 cycles of 95 ◦C for 1min, annealing at 55–68 ◦C for 1min, and extension at
72 ◦C for 1 min, and a final extension step at 72 ◦C for 10 min (Koga et al., 2014). E. coli
CFTO73, E. coli O25b:H4 (JJ1886), and E. coli DSM 22664 strains were used as a control
strain during the amplification of virulence factors.
Multi locus sequence typing
MLST analysis was used to the ST groups of the strains. PCR amplification and sequencing
of seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA and recA) were carried
according to the protocols obtained from (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli).
Primer sequences for MLST analysis were similarly obtained from http://mlst.warwick.ac.
uk/mlst/dbs/ (Table 1). The reaction mixture (50 µl) included 1.25U Tag DNA Polymerase
(Thermo Fisher Scientific) in 1× PCR buffer (Thermo Fisher Scientific), 0.2mM of each
dNTP, 3 mM MgCl2, and 1 µM of each primer (Table 1). The PCR program consisted
of a 2 min initial denaturation at 95 ◦C followed by 30 cycles of 1 min at 95 ◦C, 1 min at
annealing temp (55–65 ◦C), and 2 min at 72 ◦C, followed by a 5 min final extension at
72 ◦C .The sequencing of the PCR amplicons was performed as described above. For the
Sequence type assignment, amplicons were checked against to MLST sequence database
(https://pubmlst.org/) (Jolley & Maiden, 2010). The accession numbers were deposited
into the GenBank (MH279595–MH279614 and MH561267–MH561386).
RESULTS
Ninety-seven (93.26 %) of the obtained 104 tentative ExPEC isolates were confirmed to be
E. coli based on 16S rRNA sequence analysis. The other isolates were identified as Proteus
mirabilis (n= 2), Shigella flexneri (n= 2), and Escherichia fergusonii (n= 3). These the 97
ExPEC isolates were used for subsequent analysis.
The antibiotic susceptibility results (Table 3) showed that of the 97 strains 72 (74.22%)
were ampicillin-resistant. A total of 31 isolates (31.95%) were resistant against the
fluoroquinolone group antibiotic ciprofloxacin; 21 strains (21.65%) were susceptible
to ampicillin and gentamicin (Dataset S2 and Table 3), and 53 strains (54.63%) produced
ESBL. The antibiotic resistance of the ESBL-producing bacteria is shown in the Dataset S2.
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Table 3 Antibiotic susceptibility profiles of the ExPEC isolates.
Antibiotic Antibiotic susceptibility
R I S
n % n % n %
Ampicillin 72 74.22 n.a. n.a. 21 21.64
Amoxicillin clavulanic acid 38 39.17 n.a. n.a. n.a. n.a.
Cefuroxime axetil 64 65.97 n.a. n.a. 7 7.21
Ceftriaxone 56 57.73 n.a. n.a. n.a. n.a.
Trimethoprim-sulfamethoxazole 55 56.70 n.a. n.a. 20 41.7
Cefepime 47 48.45 6 6.18 n.a. n.a.
Gentamicin 31 31.95 1 1.03 21 20.61
Piperacillin/tazobactam 29 29.89 16 16.49 n.a. n.a.
Ciprofloxacin 31 31.95 1 1.03 8 8.24
Amikacin n.a. n.a. 18 18.55 2 2.06
Ertapenem 2 2.06 n.a. n.a. n.a. n.a.
Ceftazidime 2 2.06 n.a. n.a. n.a. n.a.
Cefuroxime 28 28.86 1 1.03 n.a. n.a.
Notes.
n.a., not applicable; R, resistant; I, intermediate resistant; S, susceptible; n, number of ExPEC isolates.
The phylogenetic classification of ExPEC isolates Clermont, Bonacorsi & Bingen (2000)
is shown in Dataset S1. The most prevalent group was D with 37 strains (38.14%), followed
by A, 29 strains (29.89%), B2 with 20 strains (20.61%), and B1 with 11 strains (11.34%).
The chuA gene was observed in ExPEC isolates belonging to the B2 and D phylogenetic
groups. Moreover, the yjaA gene was detected in only ExPEC isolates belonging to the B2
phylogenetic group. In other words, ExPEC isolates encoding chuA and yjaA genes were
assigned to the B2 phylogenetic group (n= 20). The B2 phylogroup is associated with
ST131 status (Johnson et al., 2010). Therefore, the B2 phylogroup isolates were examined
for the presence of the O25b rfb allele and that was present in six strains (Dataset S1,
highlighted in light grey). Importantly, four of the strains (ID: 6, 16, 28 and 103) were
fluoroquinolone (ciprofloxacin) resistant that is characteristic for this emerging clonal
group of ExPEC strains.
Among the studied strains, the serum resistance gene traT was the most common
(55.7%), followed by fyuA (50.5%), iutA (45.3%), PAI (41.2%), iroN (23.7.%), hlyA
(15.4%), kpsII (13.4%), ompT (13.4%), papG (12.4%), iss (9.3%), cnf1 (7.2%), ibeA
(2.06%), and sfaS (2.06%). One isolate (ID:56) carried eight, three isolates had seven, and
six isolates had six VF genes, and altogether 12 isolates carried none. The distribution of
VF genes is shown in Dataset S1 and Fig. 2. The numbers of virulence factor-associated
genes per each ExPEC isolate were varied.
The ExPEC isolates originated from various hospital departments (Fig. 1). The ExPEC
isolates originating from internal medicine (n= 18) belonged to the phylogenetic groups
B2, A, B1, and D. Of these, isolates including ID: 3, ID: 22, ID: 24 and ID: 99 belonged
to the B2 phylogenetic group. The emergency department (n= 17) had the most ExPEC
isolates followed by internal medicine. Similarly, isolates originating from the emergency
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Figure 2 Distribution of virulence genes among ExPEC isolates. The bar plot was constructed for 97
ExPEC isolates to illustrate virulence genes distribution. The numbers presented at the top of bars demon-
strated the number of virulence genes. PAI: pathogenicity-associated island (PAI) marker (n = 40), ibeA,
Invasion of brain endothelium (n = 2); hlyA, hemolysin (n = 15); cnf1, cytotoxic necrotizing factor (n =
7); iutA, Aerobactin siderophore receptor (n = 44); fyuA, Yersiniabactin (n = 49); iroN , Samochelin
siderophore receptor (n = 23); papG, P fimbriae (n = 12); sfaS, Sfa fimbriae (n = 2); iss, Episomal in-
creased serum survival; traT , serum resistance (n= 54), (n= 9); kpsII , Capsule synthesis K1 and K5 (n=
13); ompT , Episomal outer membrane protease (n= 13).
Full-size DOI: 10.7717/peerj.5470/fig-2
department belonged to phylogenetic groups B2, A, B1, and D. Of these, isolates including
ID: 5, ID: 19 and ID: 88 belonged to the B2 phylogenetic group.
A phylogenetic tree based on the maximum likelihood method under the Hasegawa-
Kishino-Yanomodel of 16S rRNA sequences was generated for the 111 strains including the
97 studied ExPEC isolates and 14 ExPEC related strains (Fig. 3, Table 2). The main clusters
that were similar were conserved. These were identified via internal branches (<0.0000).The
phylogenetic tree revealed the presence of a large strain cluster among 97 ExPEC isolates.
Under the 21 main clusters, there were 32 sub clusters. The ExPEC isolates shown in the
phylogenetic tree with blue filled circle, green filled circles, and red filled triangles were
closely related (Fig. 3). The sub-cluster with empty blue squares was clustered with some
of reference ExPEC strains including ED1a, S88, CFTO73, and APECO1. These reference
strains were a commensal strain isolated from a healthy human, a neonatal meningitis
isolate, an uropathogenic E. coli, and avian pathogenic E. coli, respectively. The ExPEC
isolates including ID:4 (B2, ESBL +), ID: 6 (B2, ESBL +), ID: 101 (B2, ESBL +), ID: 31
(A, ESBL-), and ID: 36 (B1, ESBL +) were clustered with these reference strains.
The sub-cluster shown with filled yellow squares included 8 ExPEC isolates together
with UTI89 which is uropathogenic E. coli belonging to the phylogenetic group B2. These
were clustered together, and these isolates were closely related to reference strain UTI89
(Fig. 3). However, they belonged to the different phylogenetic groups including D, A, and
B1 within this sub-cluster. However, the sub-cluster shown with filled black squares was
included two ExPEC isolates within the same phylogenetic tree (ID: 100 (B2, ESBL+) and



































































































































































































































































































































































































































































































Figure 3 Phylogenetic tree of ExPEC blood culture isolates based on 16S rRNA analysis. The evolu-
tionary history was inferred by using the Maximum Likelihood method based on the Hasegawa–Kishino–
Yano model (Hasegawa, Kishino & Yano, 1985). The bootstrap consensus tree inferred from 1,000 repli-
cates (Felsenstein, 1985) is taken to represent the evolutionary history of the taxa analyzed (Felsenstein,
1985). Branches corresponding to partitions reproduced in less than 50% bootstrap replicates are col-
lapsed. Initial tree(s) for the heuristic search were obtained by applying the Neighbor-Joining method to
a matrix of pairwise distances estimated using the Maximum Composite Likelihood (MCL) approach.
The analysis involved 111 nucleotide sequences (97 ExPEC isolate sequences and of the 14 related Ex-
PEC strain sequences fetched from the NCBI GenBank database). All positions containing gaps and miss-
ing data were eliminated. There were a total of 382 positions in the final dataset. Evolutionary analyses
were conducted in MEGA7 (Kumar, Stecher & Tamura, 2016). The symbols shown in the tree indicative
for the sub-clusters that were closely related (blue filled circle, green filled circle, and red filled triangle)-
(empty blue square and filled yellow square)-(empty lilac circle and aqua filled circle)-(purple filled tri-
angle and lilac filled rhomb)-(empty black triangle)-(empty red circle)-(black filled square)-(red filled
square)-(grey filled triangle)-(lime filled triangle)-(dark green filled circle)-(orange filled triangle)-(empty
black rhomb)-(black filled circle)-(yellow filled triangle)-(empty orange square)-(empty black square)-
(blue filled rhomb)-(empty black circle).
Full-size DOI: 10.7717/peerj.5470/fig-3
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Table 4 Sequence Type classification and allelic profiles of the phylogroup B2 of the ExPEC isolates.
Isolate ID ST adk fumC gyrB icd mdh purA recA clonal complex Phylogenetic
classification
ESBL (+/-) O25
3 131 53 40 47 13 36 28 29 ST131 Cplx B2 + +
4 131 53 40 47 13 36 28 29 ST131 Cplx B2 + +
5 95 37 38 19 37 17 11 26 ST95 Cplx B2 −
6 131 53 40 47 13 36 28 29 ST131 Cplx B2 + +
8 80 13 24 19 14 23 1 10 ST568 Cplx B2 −
16 131 53 40 47 13 36 28 29 ST131 Cplx B2 + +
17 14 14 14 10 14 17 7 10 ST14 Cplx B2 −
19 10 550 11 4 8 8 8 2 ST10 Cplx B2 +
22 69 21 35 27 6 5 5 4 ST69 Cplx B2 −
24 131 53 40 47 13 36 472 29 ST131 Cplx B2 +
28 131 53 40 47 13 36 28 29 ST131 Cplx B2 + +
39 131 53 40 47 13 36 28 29 ST131 Cplx B2 +
53 1722 101 4 97 29 70 158 2 None B2 −
88 141 13 52 10 14 17 25 17 None B2 −
95 131 53 40 47 13 36 28 29 ST131 Cplx B2 +
96 1722 101 4 97 29 70 158 2 None B2 −
99 88 518 4 12 1 20 12 7 ST23 Cplx B2 +
100 131 53 40 25 13 36 28 29 ST131 Cplx B2 +
101 998 13 52 156 14 17 25 17 None B2 +
103 131 53 40 47 13 36 28 29 ST131 Cplx B2 + +
Notes.
ESBL, Extended-Spectrum β-lactamase; O25, O25 serotype of ExPEC; ST, sequence type.
ID: 24 (B2, ESBL +)). In the sub-group shown as empty circle, 2 ExPEC isolates (ID: 103
(B2, ESBL +) and ID: 98 (A, ESBL-)) were closely related to JJ1886 which is a ST131 clone
(Fig. 3 and Table 2).
MLST analysis is a standard technique used to compare phylogroups and determine
ExPEC lineages (Dale & Woodford, 2015). Thereby, MLST analysis of 20 ExPEC isolates
(Isolate IDs: 3, 4, 5, 6, 8, 16, 17, 19, 22, 24, 28, 39, 53, 88, 95, 96, 99, 100, 101, and 103)
belonging to the B2 phylogenetic group was carried out. The ST of 10 isolates out of 20 was
identified as ST131. The others represented STs ST95, ST14, ST10, ST69, ST1722, ST141,
ST88, ST80 and ST998 (https://pubmlst.org/). The ExPEC isolates identified as ST131 and
related alleles were found to be ESBL producers (Table 4). However, some ExPEC isolates
included in the B2 phylogenetic group (Isolate ID: 5 (ST95), 8 (ST80), 17 (ST14 and 96
(ST1722) had no antibiotic resistance. Insertion and/or deletion were detected in isolate
ID:5 for the adk gene for allele 37. Other insertions and deletions were as follows: isolate
ID:8 adk gene for allele 13, ID: 24 for the adk gene allele 53, ID:39 for the adk gene allele
53, ID:8 for the recA gene allele 10, and ID:16 for the fumC gene allele 40: 101C→ 101T.
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DISCUSSION
ExPEC is a very important bacterium causing many extraintestinal infections including
urinary tract infections and fatal bacteraemia. The pathogenicity of these bacteria may
depend on a variety of virulence determinants (Dale & Woodford, 2015). ExPEC represents
many complex phylogenetic groups, and several clonal groups and lineages are associated
with many different human extraintestinal infections (Fratamico et al., 2016). The presence
of multiple antibiotic resistances in different phylogenetic groups demonstrates the
importance of ExPEC in terms of public health. In this study, ExPEC isolates were
characterized in terms of phylogenetic relationships, virulence determinants, sequence
types, and antibiotic resistance. We detected that 74.22% of the ExPEC isolates were
resistant to ampicillin, and over 50% of ExPEC isolates have produced ESBL. The most
prevalent phylogroups was D and A. Serum resistance, yersiniabactin, and pathogenicity
islands were the most commonly encountered virulence determinants. The ExPEC isolates
assigned to ST131 lineage were shown to be ESBL producers. Isolates (ID: 6, 16, 28, and
103) belonging to the ST131 O25 clonal group were resistant to ciprofloxacin which is a
fluoroquinolone. The ExPEC isolates were mostly originated from emergency and internal
medicine departments.
Antibiotic resistance against sulphonamides, fluoroquinolones, aminoglycosides, β-
lactams including cephalosporins, and carbapenems, has been encountered among the
ExPEC isolates (Blanco et al., 2011; Cerquetti et al., 2010; Feglo et al., 2013; Ranjan
et al., 2016). In addition to the ampicillin resistance (74.22%), isolates studied
here showed resistance to cefepime (4th generation cephalosporin, 48.45%), gentamicin
(aminoglycoside, 31.95%), and piperacillin-tazobactam (β-lactam and β-Lactamase
inhibitor, 29.89%), and trimethoprim-sulfamethoxazole (sulphonamide 56.70%) (Table 3).
Due to the heterogeneity of the ExPEC isolates seen in different studies, the observed
antibiotic resistance distribution seen here could be differentiated among the ExPEC
isolates. For example, the ciprofloxacin resistance rate was low in the Japanese study
(Matsumura et al., 2017); here, it was 31.95% among the ExPEC isolates (Table 3).
The ESBL-producing ExPEC causes difficulties in the treatment of extraintestinal
infections, and this has been noted all around the world (Arvand, Moser & Pfeifer, 2013;
Padmini et al., 2017). The ESBL type CTX-M poses themost threat to the public health. The
incidence rates are variable: In Ghana, 49.4% of nosocomial ExPEC produced ESBL (Feglo
et al., 2013) but 54.63% in this study. In Turkey, the CTX-M type β-lactamase producing
E. coli increased from 53% in 2008 (Yumuk et al., 2008) to 83.5% in 2017 (Aktaş et al.,
2017). This is likely due to the horizontal gene transfer among E. coli (Park et al., 2012).
In particular, E. coli ST131 has been drawn particular attention in accordance with higher
virulence and resistance profiles including CTX-M-15 type ESBL producing a clonal lineage
(Chung et al., 2012; Peirano, Costello & Pitout, 2010). The ST131, ST95, ST998, ST73, and
ST69 have been most common clonal lineages worldwide (Alghoribi et al., 2015; Colpan
et al., 2013; Doumith et al., 2015). Here, we detected 10 different ST of which ST131 was
most common. The others are listed in Table 4. We note that, we did not encounter any
resistant isolates among the ST14, ST95, ST80 and ST1722 clonal lineages (Dataset S2), in
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line with the observations that different ExPEC clonal lineages display different antibiotic
susceptibilities (Doumith et al., 2015). Therefore, this could indicate that ExPEC in the
same ST might be genetically diverse (Dale & Woodford, 2015).
Phylogenetic classification of ExPEC isolates can be performed based on the detection
of the chuA, and yjaA genes, and particular DNA fragment known as TSPE4.C2 (Clermont,
Bonacorsi & Bingen, 2000). Phylogenetic groups D and B2 of ExPEC have higher virulence
in humans (Fratamico et al., 2016). Comparably, we detected D (38.14%, 37/97) and
B2 (20.61%, 20/97) phylogenetic groups among ExPEC isolates. The detection rate of
phylogenetic group A (29.8%, 29/97) was higher than phylogenetic group B2. In other
studies, B2 was reported to be most common phylogenetic group in ExPEC (Koga et
al., 2014; Micenkova et al., 2016). The B2 group has usually been associated with ST131
(Johnson et al., 2010). Our B2 phylogroup ExPECs were examined for the O25b rfb allele
because serotype O25 and fluoroquinolone-resistant ExPECs are an emerging clonal group.
This was present in 6 isolates (Dataset S1 light grey highlighted and Table 4). Of these, four
(ID: 6, 16, 28 and 103) were fluoroquinolone resistant. Therefore, they may represent the
ST131 O25 emerging clonal group (Dataset S2).
Virulence factors related to ExPEC pathogenicity are diverse and are generally divided
into 5 main classes: adhesins, toxins, invasins, iron acquisition systems and capsule
production. Finding a high prevalence of serum resistance factors among the strains is
feasible because the strains were isolated from blood cultures where only serum-resistant
pathogens could survive (Miajlovic et al., 2016). Iron uptake systems include aerobactin and
yersiniabactin siderophores. These are necessary for the bacteraemia and the emergence
of a successful infection (Dale & Woodford, 2015; Subashchandrabose & Mobley, 2015).
A high incidence of aerobactin siderophore (iutA) and yersiniabactin (fyuA) genes was
found in this study (Dataset S1 and Fig. 2). However, we observed no correlation between
phylogenetic groups and virulence genes distribution. While the ExPEC strains belonging
to the phylogenetic group A are generally considered to be commensal strains and non-
pathogenic, virulence factor genes including fyuA were observed in phylogenetic group
A in this research. Accordingly, Cyoia et al. (2015) reported that fyuA was detected in
commensal strains of ExPEC, and PAI was detected in B2 compared to other phylogenetic
groups of ExPEC (Cyoia et al., 2015). Similarly, a higher incidence of PAI was detected in
ExPEC isolates belonging to the phylogenetic groups B2 and D than in B1 and A. Therefore,
ExPEC virulence factors could be detected in commensal E. coli strains. It can be inferred
from that the acquisition of virulence factors in ExPECs belonging to the phylogenetic
group A is associated with horizontal gene transfer of the mobile genetic elements e.g.,
pathogenicity islands, plasmids and phages. For instance, pathogenicity islands mediates
integration regions for the virulence genes thus acquisition of the virulence genes can be
occurred in the genomic region (Leimbach, Hacker & Dobrindt, 2013).
Johnson & Stell (2000) stated that there were associations among VFs. For example, by
the pap and hlyA, fyuA and PAI markers. The hlyA and pap are associated virulence factors
among B2 strains but not all of the B2 strains (Johnson & Stell, 2000). A few ExPEC isolates
belonging to the B2 group had hlyA along with the pap gene (ID: 8 and ID: 17). However,
other B2 strains had only the hlyA gene (IDs: 3, 6, 8, 17, 18and 28). Our findings could
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demonstrate that not all B2 strains have both hlyA and pap. Both the PAI marker and
fyuA were detected among ExPEC isolates belonging to the phylogenetic groups B2 and D
(Dataset S1). Therefore, it can be concluded that we did not observe any clear a virulence
association among the ExPEC isolates.
Virulence factors related to ExPEC pathogenicity are variable ranging from colonisation
to invasion factors required for the establishment and prolonged infection. Virulence factors
could be associated with infection site including urinary tract infection-associated VFs,
neonatal meningitis-associated VFs and bacteraemia-associated VFs (Dale & Woodford,
2015). Moreover, the VFs of ExPECs could be a molecular marker for contribution to other
pathotypes of E. coli strains. For example, enteroinvasive E. colimay includeVFs and genetic
PAI markers related to uropathogenic E.coli (Da Silva, De Mello Santos & Silva, 2017).
The 16S rRNA sequences in the 111 ExPEC strains (Fig. 3, Dataset S1 and Table 2)
were used for phylogenetic analysis. The phylogenetic tree was obtained via the maximum
likelihood method and demonstrated a large cluster among the 97 ExPEC isolates. The 16S
rRNA sequences are highly conserved, and they could not discriminate between the ExPEC
isolates, as noted also elsewhere (Lukjancenko, Wassenaar & Ussery, 2010). However,
16S rRNA is useful for the studying bacterial phylogeny and phylogenetic relationships
(Suardana, 2014). Nevertheless, closely related ExPEC isolates were observed in a bootstrap
consensus tree are shown with blue filled circles, green filled circles, and red filled triangles
(Fig. 3). Although the phylogenetic groups were different, phylogenetic group B2, D, and
B1 were clustered together. Similarly, a close relatedness was observed between reference
strains and ExPEC isolates. For example, EC958 and JJ1886 were clustered together with
B2 and A phylogenetic groups (ID: 103 and ID: 98). The related reference strains were
shown with empty circles (Fig. 3). Therefore, we can deduce that the ExPEC isolates from
different phylogenetic groups could be clustered together.
CONCLUSIONS
The ExPEC strains has a broad range of virulence determinants and clonal lineages. Thus,
certain problems can occur during the treatment of extraintestinal infections. An increased
antibiotic resistance including β-lactamases could lead to the emerge of new pandemic
clones. In line with other studies, we detected ampicillin resistance the most followed
by cefuroxime axetil (cephalosporin) among ExPEC isolates included in this study. We
also detected an antibiotic resistant ST131 clonal lineage along with other STs. These are
among the most problematic clones worldwide. The detection of virulence factor genes in
non-pathogenic phylogenetic groups A and B1 signified that the presence of the virulence
genes might not be directly correlated to the phylogenetic group. Moreover, the high
detection of serum resistance factors might be a prerequisite virulence factor for bacteria
that cause systemic bloodstream infections. Also, yersinabactin could be a characteristic
virulence factor for the bacteremic E. coli isolates. Moreover, ExPEC isolates belonging to
the same phylogenetic group can have variable resistance and virulence properties.
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